#868: Tim’s Founder Kitchen — From Brainstorm to The President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics)
The U.S. is losing its biotech crown to China and Australia not because of inferior science, but because its regulatory system is so slow and costly that it forces innovation overseas—Jake Becraft, CEO of Strand Therapeutics, reveals how a single patient’s survival story, combined with a razor-sharp messaging strategy, triggered a congressional hearing and landed a biotech policy agenda in the Oval Office within just two months. This isn’t just a tale of a breakthrough therapy; it’s a blueprint for how to weaponize clarity, urgency, and narrative power to rewrite the rules of innovation. By replacing the FDA’s 18-month, $25 million IND approval process with a clinical trial notification (CTN) system modeled on Australia’s, Becraft and Tim Ferriss engineered a system that could cut trial setup from years to weeks—freeing regulators to focus on efficacy, not bureaucracy. The real revolution isn’t in the science, but in the infrastructure: AI can design any protein, but without scalable delivery systems, breakthroughs remain trapped in labs. The future of medicine isn’t one-size-fits-all drugs—it’s a modular, platform-based ecosystem where each delivery method (tumors, T-cells, organs) requires its own tailored infrastructure, akin to Uber Eats for medicine. Success isn’t an IPO or acquisition—it’s building a generational platform like SpaceX or Apple, powered by patient capital and a bold, consistent long-term story.
The U.S. biotech industry is losing its global edge due to an 18-month, $25M FDA IND process that pushes innovation overseas to China and Australia.
A single patient’s survival story (now 1.5 years cancer-free) became the emotional core of a messaging strategy that influenced U.S. presidential policy within two months.
Replace FDA approval with a Clinical Trial Notification (CTN) system—like Australia’s—to cut trial setup time from 18 months to weeks and free the FDA to focus on efficacy.
The real bottleneck in medicine isn’t discovery—it’s deployment: AI can design any protein, but we can’t deliver it to the liver, kidney, or brain at scale.
True therapeutic platforms are like delivery systems—efficient, adaptable, and scalable, akin to Uber Eats for medicine, not just the drug itself.
…and 3 more takeaways available in PodZeus
The Holy Grail of Genetic Medicine
“In genetic medicine, I would call it the holy grail for the last 30 years has been thinking about how do we administer intravenous, which means into the bloodstream, genetic medicines that can get to places throughout the body.”
The Birth of a Vision: From Dinner to the Oval Office
Tim recounts the initial dinner in Boston with Jake Becraft, Phil Strandwitz, and Jamie, setting the stage for a two-month journey from a brainstorming session to a policy conversation with the President.
The Science Behind the Breakthrough
Jake explains the core mechanism: using RNA to trick cancer cells into sending their own immune-activating signals, turning tumors into targets the immune system can recognize and destroy.
The Power of the Patient Story
“You don't have to be an oncologist to look at that scan and understand the extent of which this patient responded. Sort of just riddled and then no more.”
The Problem with 'Delivery' as a Catch-All
“It's three children in their father's trench coat pretending to be an adult. It's like, we're delivery and then you open it up and it's like potency, specificity and delivery are all here inside.”
“But in the president's recommendations, there is this exact idea of removing barriers to getting early stage experimental medicines to American patients in America through FDA reform.”
“I like to say you don't have to be an oncologist to look at that scan and understand the extent of which this patient responded. Sort of just riddled and then no more.”
“It's three children in their father's trench coat pretending to be an adult. It's like, we're delivery and then you open it up and it's like potency, specificity and delivery are all here inside.”
Host
Guest
Tim Ferriss
person
Strand Therapeutics
organization
Jake Becraft
person
SpaceX
organization
FDA
organization
Genentech
organization
Amazon
organization
Elon Musk
person
CRISPR
other
Apple
organization
The Chris Voss Show Podcast – Heart of the Deal: The Insider’s Guide to Medical Device Sales Success by Dr. Joseph DeAngelis, Kevin Matthews
30m • 5/30/2026
Is Waymo's Lead Becoming Insurmountable?
40m • 5/30/2026
DTNS May 2026 in Review
24m • 5/30/2026
May 2026 Random Ramblings
27m • 5/31/2026
Does Sunscreen Stop Your Skincare From Working? - Episode 426
45m • 6/1/2026
#869: Max Levchin, PayPal and Affirm — The Path from The Soviet Union to Building Multi-Billion Dollar Companies (Plus: Real-World Socialism vs. Capitalism)
1h 58m • 6/9/2026
#870: Sebastian Mallaby, Biographer of Demis Hassabis — Lessons from 100+ AI Insiders on The Race to Superintelligence, The Religion of AI, and Spotting Breakthroughs Early
1h 46m • 6/16/2026
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime